Global X Fds genomic biotech shares owned by Oppenheimer Asset Management
Quarter-by-quarter ownership of Global X Fds genomic biotech (GNOM) shares owned by Oppenheimer Asset Management
from 13F filings
Historical chart of Oppenheimer Asset Management investment in Global X Fds genomic biotech
Tip: Access up to 7 years of quarterly data
All positions including Global X Fds genomic biotech held by Oppenheimer Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Global X Fds genomic biotech by Oppenheimer Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $699k | 62k | 11.38 |
| 2023-09-30 | $550k | 54k | 10.17 |
| 2023-06-30 | $588k | 49k | 12.12 |
| 2023-03-31 | $580k | 47k | 12.32 |
| 2022-12-31 | $564k | 45k | 12.65 |
| 2022-09-30 | $585k | 47k | 12.56 |
| 2022-06-30 | $567k | 46k | 12.22 |
| 2022-03-31 | $674k | 45k | 15.02 |
| 2021-12-31 | $700k | 35k | 19.85 |
| 2021-09-30 | $637k | 29k | 22.15 |
| 2021-06-30 | $568k | 23k | 24.90 |
| 2021-03-31 | $405k | 18k | 22.48 |
More positions owned by Oppenheimer Asset Management
View all positions for Oppenheimer Asset Management